Skip to main content
Medical information Clinical review pending

Genetic Testing

ZNF81 Gene Mental Retardation X-Linked Type 45 Genetic Test

Genetic test using Next Generation Sequencing (NGS) to identify mutations in the ZNF81 gene, associated with X-linked intellectual disability. Helps diagnose genetic causes of cognitive impairment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (collected in an EDTA tube) or extracted DNA.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the ZNF81 Gene Mental Retardation X-Linked Type 45 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with unexplained intellectual disability or developmental delay.
  • ✓Family history of X-linked intellectual disability.
  • ✓Patients with symptoms suggestive of ZNF81-related disorders.
  • ✓Genetic counseling for families with affected members.
  • ✓Prenatal diagnosis in high-risk pregnancies (requires specialist consultation).
02

In plain language

What this test helps you understand

This test helps identify mutations in the ZNF81 gene, which are associated with X-linked intellectual disability. It aids in confirming a diagnosis, understanding the genetic cause of developmental delays, and providing information for genetic counseling.
The ZNF81 Gene Mental Retardation X-Linked Type 45 NGS Genetic DNA Test is a diagnostic tool used to identify specific genetic mutations in the ZNF81 gene. These mutations are linked to certain types of intellectual disability, particularly those affecting males and inherited in an X-linked pattern. This test utilizes advanced Next Generation Sequencing (NGS) technology to provide a detailed analysis of the gene. Understanding the genetic basis of cognitive impairment is crucial for accurate diagnosis, appropriate management, and informed family planning. This test can help healthcare providers understand the underlying cause of a patient's condition and guide treatment decisions.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Confirm with the laboratory before booking.
SampleBlood sample (collected in an EDTA tube) or extracted DNA.
MethodologyNext Generation Sequencing (NGS) is used to analyze the ZNF81 gene for mutations.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test specifically analyzes the ZNF81 gene. It does not detect mutations in other genes that can cause intellectual disability. A negative result does not rule out a genetic cause for the condition. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The ZNF81 gene provides instructions for making a protein involved in brain development. Mutations in this gene are linked to certain types of intellectual disability.
This test is typically recommended for individuals with unexplained intellectual disability, developmental delays, or a family history of related conditions.
A blood sample is usually required for this test. Alternatively, previously extracted DNA can be used. Confirm with the laboratory before booking.
Confirm with the laboratory before booking.
Results will indicate whether specific mutations in the ZNF81 gene were detected. Discuss the results with your doctor or a genetic counselor to understand their implications.
Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp